Literature DB >> 10356700

Neuraxial infusion for pain control: when, why, and what to do after the implant.

P S Staats1.   

Abstract

Neuraxial infusion therapy is an excellent option for selected patients with severe pain. Both epidural and intrathecal systems can be effective for multiple pains and are titratable, nondestructive, and very safe. Intraspinal therapy requires low opioid doses, has no motor, sensory, or sympathetic effects, and may have a lower side-effect liability than systemic therapy. Although most oncologists do not refer patients for intrathecal therapy, a recent study indicated that more oncologists would if they knew more about the therapy and if patients requested it. When permanent systems are used, close follow-up is essential. To obtain the maximum benefit from intraspinal therapy, pain management physicians and oncologists must communicate with each other and work together as partners.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356700

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  2 in total

1.  Intrathecal infusions for intractable cancer pain: a qualitative study of the impact on a case series of patients and caregivers.

Authors:  Philippa Hawley; Elizabeht Beddard-Huber; Cameron Grose; William McDonald; Daphne Lobb; Louise Malysh
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

2.  Retrospective Analysis of Intrathecal Drug Delivery: Outcomes, Efficacy, and Risk for Cancer-Related Pain at a High Volume Academic Medical Center.

Authors:  Dawood Sayed; Forrest Monroe; Walter N Orr; Milind Phadnis; Talal W Khan; Edward Braun; Smith Manion; Andrea Nicol
Journal:  Neuromodulation       Date:  2018-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.